CoChat

Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate

Bonavita, C.D., Bisagno, V., Bonelli, C.G., Acosta, G.B., Rubio, M.C., Wikinski, S.I. · 2002 · Neuropharmacology

The DOI matches its Crossref record; 31 of the 33 references it cites were found in a registry or an index.

Abstract

Benzodiazepines are anxiolytic, anticonvulsant, sedative and hypnotic compounds usually prescribed on a long-term basis. Chronic treatment with these compounds induces tolerance, which has been extensively attributed to modifications in the GABAergic neurotransmission. However, a compensatory increase in the excitatory response, named as an oppositional response, has also been put forward as a means for explaining such tolerance. Changes in the excitatory neurotransmission have been found in withdrawn rats after a long treatment with benzodiazepines but these modifications have not been conclusively studied during tolerance. In this work we studied several parameters of the glutamatergic neurotransmission in rats made tolerant to the sedative effect of 3 mg/kg (i.p.) of lorazepam (LZ). We found a decrease in the affinity of cortical NMDA receptors for (3)H-glutamate (K(D): 124.4 +/- 13.3 nM in tolerant rats, 71.6 +/- 10.4 nM in controls, P<0.05) together with a decrease in the in vitro 60 mM K(+)-stimulated cortical glutamate release (59+/- 12% vs. 153 +/- 38%, tolerant rats vs. controls, P<0.05). We conclude that tolerance to the sedative effect of LZ correlates with a decreased sensitivity for glutamate that may in turn diminish the cortical response to a chemical stimulus. Our findings constitute an evidence against the oppositional model of pharmacodynamic tolerance in this experimental condition.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0028-3908(02)00012-6

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Cited by

See all 19

Metadata

Authors
Bonavita, C. D., Bisagno, V., Bonelli, C. G., Acosta, G. B., Rubio, M. C., & Wikinski, S. I.
Affiliations
Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
Corresponding author
Bonavita, C.D.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2002-04
Volume
42
Issue
5
Pages
619-625
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2077885190
Cited by
19
References
33
Citations by year
2026: 1 · 2022: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
FWCI
0.35
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Agencia Nacional de Promoción Científica y Tecnológica
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
lorazepam, benzodiazepine tolerance, sedative effects, glutamatergic neurotransmission, GABAergic neurotransmission
MeSH terms
Animals, Binding Sites, Cerebral Cortex, Dose-Response Relationship, Drug, Drug Tolerance, Hypnotics and Sedatives, Lorazepam, Male, Motor Activity, Receptors, N-Methyl-D-Aspartate, Rats, Wistar, Glutamic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate. https://app.cochat.ai/papers/10.1016/s0028-3908(02)00012-6
The paper
Bonavita, C. D., Bisagno, V., Bonelli, C. G., Acosta, G. B., Rubio, M. C., & Wikinski, S. I. (2002). Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate. Neuropharmacology. https://doi.org/10.1016/s0028-3908(02)00012-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.